about
Epigenetics of gastrointestinal diseases: notes from a workshopImage-Based Molecular Phenotyping of Pancreatic Ductal AdenocarcinomaCovalent-Allosteric Inhibitors to Achieve Akt Isoform-SelectivityTFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancerProton Irradiation Increases the Necessity for Homologous Recombination Repair Along with the Indispensability of Non-Homologous End JoiningPreclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal CancerN-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastomaTherapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
P50
Q57179338-9C9E787F-FAF2-4EFA-A31B-6912152BD526Q90191986-B05AF6AA-9DB5-4146-A1F7-D77F13FF2FD1Q90478449-1A8AE186-B266-425F-B2D0-3E65CF132DCBQ90482668-732900AE-DD90-402F-BD66-B5852C4F1366Q91671746-C91D623E-845A-45A6-81DA-643A291C3A0BQ92281945-0496C1C2-903F-46A0-A011-3016D0D68037Q94452122-620D0DF7-1F01-4C83-A97E-593D46F77832Q94521431-8D6D703B-2899-4E2A-AC4B-6B41BF3DB8B5
P50
description
researcher
@en
name
Jens Siveke
@en
type
label
Jens Siveke
@en
prefLabel
Jens Siveke
@en
P31
P496
0000-0002-8772-4778